Novonesis is a strong business with stable margins and high ROIC, but recent growth rates have declined. See why NVZMF stock ...

To supplement our unaudited consolidated financial statements presented on a GAAP basis, we disclose certain non-GAAP ...

ARS Pharmaceuticals launched Neffy, the first FDA-approved needle-free epinephrine nasal spray for severe allergic reactions. See why SPRY stock is a Buy.

Boston Scientific Corporation (NYSE: BSX) generated net sales of $4.561 billion during the fourth quarter of 2024 ...

PHILADELPHIA, Feb. 04, 2025 (GLOBE NEWSWIRE) -- Axalta Coating Systems Ltd. (NYSE:AXTA) ("Axalta”), a leading global coatings ...

According to Viet, a member of the Vietnam Institute for Economic and Policy Research, enterprises from Northeast Asia could move part of their production to Southeast Asia to avoid tariffs, which ...

W.W. Grainger operates in the highly fragmented maintenance, repair, and operations product distribution market, where its over $14 billion of high-touch solutions sales in North America represents ...

Deckers Brands (NYSE: DECK), a global leader in designing, marketing, and distributing innovative footwear, apparel, and accessories, today announced ...

International Business Machines Corp. gave a stronger-than-expected revenue growth outlook for the coming years led by the ...

Roche has reported a 7% increase in full-year 2024 sales at constant exchange rates (CER), reaching CHF 60.5bn ($66.9bn). The growth was driven by strong demand for new medicines, which offset ...

net sales and organic sales growth guidance for the full-year 2025. For fiscal 2025, the company now projects earnings per share growth in mid-single-digit percentage and adjusted earnings per ...

Novartis NOVN1.90%increase; green up pointing triangle forecasts further profit and sales growth this year after beating analysts’ expectations in the fourth quarter of 2024, despite looming ...